相关实验视频

Updated: Jul 27, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

胆血症:为了获得视网膜基因治疗的监管批准

Imran H Yusuf^1,2, Robert E MacLaren^3,2

¹Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.

Cold Spring Harbor perspectives in medicine

|June 5, 2023

概括

胆红血症是一种罕见的X相关眼睛疾病,导致逐渐视力丧失. 基因疗法显得有前途,但临床试验和监管机构批准的挑战仍然存在.

科学领域:

眼科医生眼科眼科
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

胆血症是一种X链接的遗传性视网膜变性.
它涉及视网膜色素上皮质 (RPE),胸膜和视网膜的逐渐退化.
症状包括夜视减弱和最终失明.

研究的目的:

审查目前的腺相关病毒基因疗法治疗胆血症的现状.
讨论临床试验和监管机构对这种疾病的批准方面的挑战.

主要方法:

对胆固醇性病的基因治疗现有临床试验数据的审查.
分析与疾病进展和结果测量相关的挑战.

主要成果:

腺相关的病毒基因疗法在临床试验中显示了一些益处.
在慢慢进展的疾病中证明疗效是困难的,比如胆固醇血症.
通过手术干预来测量视力敏度的改善是复杂的.

结论:

尽管面临挑战,但在开发治疗胆固醇血症方面取得了重大进展.
需要进一步的研究来克服临床试验设计和监管途径的障碍.

更多相关视频

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Published on: December 7, 2016

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...